Preview

Journal Infectology

Advanced search

Vasсulitis of skin at the patient with a chronic hepatitis C, the admixed сryoglobulinemia and activity current chronic CMV infection (the description of a clinical case)

https://doi.org/10.22625/2072-6732-2011-3-3-114-119

About the Authors

D. L. Sulima
Saint-Petersburg State Medical University by I.P. Pavlov, Saint-Petersburg
Russian Federation


O. V. Gorchakova
Saint-Petersburg State Medical University by I.P. Pavlov, Saint-Petersburg
Russian Federation


N. V. Sabadash
Saint-Petersburg State Medical University by I.P. Pavlov, Saint-Petersburg
Russian Federation


V. E. Karev
Research Institute of Children Infection Diseases FMBA of Russia, Saint-Petersburg
Russian Federation


V. M. Labazanov
Clinical Infection Diseases Hospital named by S.P. Botkin, Saint-Petersburg
Russian Federation


References

1. Якобсон, И.М. Внепеченочные проявления хронического гепатита С / И.М. Якобсон [и др.] // Клин. гастроэнтерол. и гепатол. – 2011. – Т. 4, № 1. – С. 55–68.

2. Zignego, A.L. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach / A.L. Zignego [et al.] // Dig. Liver Dis. – 2007. – V. 39. – P. 2–17.

3. Monti, G. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias / G. Monti [et al.] // Arch. Intern. Med. – 2005. – V. 165. – P. 101–105.

4. Fabrizi, F. Therapy of hepatitis C virus-associated glomerulonephritis: Current approaches / F. Fabrizi [et al.] // J. Nephrol. – 2008. – V. 21. – P. 813–825.

5. Harrison, S.A. Insulin resistance among patients with chronic hepatitis C: Etiology and impact on treatment / S.A. Harrison // Clin. Gastroenterol. Hepatol. – 2008. – V. 6.– P. 864–876.

6. Moucari, R. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis / R. Moucari [et al.] // Gastroenterol. – 2008. – V. 134. – P. 416–423.

7. Wang, C.S. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study /C.S. Wang [et al.] // Am. J. Epidemiol. – 2007. – V. 166. – P. 196–203.

8. Hsu, F.C. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study / F.C. Hsu [et al.] // J. Rheumatol. – 2003. – V. 30. – P. 455–458.

9. Fox, R.I. Sjogren’s syndrome / R.I. Fox // Lancet. – 2005. – V. 366. – P. 321–331.

10. Leigh, J.P. Costs of hepatitis C / J.P. Leigh [et al.] //Arch. Intern. Med. – 2001. – V. 161. – P. 2231–2237.

11. Casato, M. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: A multicenter case-control study using magnetic resonance imaging and neuropsychological tests / M. Casato [et al.] //J. Rheumatol. – 2005. – V. 32. – P. 484–488.

12. Spiegel, B.M. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment /B.M. Spiegel [et al.] // Hepatology. – 2005. – V. 41. – P. 790–800.

13. Cacoub, P. Cryoglobulinemia vasculitis / P. Cacoub [et al.] // Curr. Opin. Rheumatol. – 2002. – V. 14, № 1. – P. 29–35.

14. Ferri, C. Cryoglobulins / C. Ferri, A.L. Zignego, S.A. Pileri // J. Clin. Pathol. – 2002. – V. 55, № 1. – P. 413.

15. Younossi, Z. The effects of HCV infection and management on health-related quality of life / Z. Younossi, J. Kallman // J. Hepatol. – 2007. – V. 45. – P. 806–816.

16. Ferri, C. Cryoglobulinemic vasculitis / C. Ferri, M.T. Mascia // Curr. Opin. Rheumatol. – 2006. – V. 18. – P. 54–63.

17. Saadoun, D. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis / D. Saadoun [et al.] // Curr. Opin. Rheumatol. – 2008. – V. 20. – P. 23–28.

18. Saadoun, D. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy / D. Saadoun [et al.] // Rheumatol. – 2005. – V. 46. – P. 2917–2925.

19. Saadoun, D. Hepatitis C-associated mixed cryoglobulinemia: A crossroad between autoimmunity and lymphoproliferation / D. Saadoun [et al.] // Rheumatol. – 2007. – V. 52. – P. 1234–1242.

20. Cacoub, P. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: Where do we stand? / P. Cacoub [et al.] // Ann. Rheum. Dis. – 2008. – V. 67. – P. 283–287.

21. Cavallo, R. Rituximab in cryoglobulinemic peripheral neuropathy / R. Cavallo [et al.] // J. Neurol. – 2009. – V. 256. – P. 1076–1082.

22. Saadoun, D. Rituximab plus peg-interferon/ribavirin compared to αpeg-interferon/ribavirin in hepatitis C related mixedα cryoglobulinemia / D. Saadoun [et al.] // Blood. – 2010. – V. 116. – P. 326–334.

23. Lamprecht, P. Cryoglobulinemic vasculitis /P. Lamprecht, A. Gause, W.L. Gross // Arthritis and rheumatism. – 1999. – V. 42, № 12. – P. 2507–2516.

24. Тишкевич, О.А. Системный цитомегаловирусный васкулит у ВИЧ-инфицированного больного / О.А. Тишкевич [и др.] // Эпидемиология и инфекционные болезни. – 2001. – № 1. – С. 31–36.


Review

For citations:


Sulima D.L., Gorchakova O.V., Sabadash N.V., Karev V.E., Labazanov V.M. Vasсulitis of skin at the patient with a chronic hepatitis C, the admixed сryoglobulinemia and activity current chronic CMV infection (the description of a clinical case). Journal Infectology. 2011;3(3):114-119. (In Russ.) https://doi.org/10.22625/2072-6732-2011-3-3-114-119

Views: 537


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-6732 (Print)